Results 211 to 220 of about 23,326 (221)

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Mechanisms of Dupilumab

Clinical and Experimental Allergy, 2020
Hani Harb, Talal A Chatila
exaly  

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Lancet, The, 2016
Sally E Wenzel, Mario Castro, Jonathan Corren   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Lisa A Beck, Thomas Bieber, Andrew Blauvelt   +2 more
exaly  

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

Gastroenterology, 2020
Ikuo Hirano, Evan Dellon, Jennifer Davidson Hamilton   +2 more
exaly  

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

New England Journal of Medicine, 2018
Ian D Pavord, Jorge F Maspero, Sally E Wenzel   +2 more
exaly  

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

British Journal of Dermatology, 2018
Marjolein de Bruin-Weller, D Thaçi
exaly  

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

New England Journal of Medicine, 2018
Klaus F Rabe, Parameswaran Nair, Guy G Brusselle   +2 more
exaly  

Conjunctivitis in dupilumab clinical trials

British Journal of Dermatology, 2019
Bolanle Akinlade, E Guttman-Yassky, Marjolein de Bruin-Weller   +2 more
exaly  

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

New England Journal of Medicine, 2014
Lisa A Beck, Jennifer Davidson Hamilton, Thomas Bieber   +2 more
exaly